Edward Christopher "Chris" Dee, MD
@EChrisDee
Followers
1K
Following
32K
Media
476
Statuses
2K
🇵🇭🇨🇦🇺🇸 | @MSKCancerCenter @HarvardMed @Yale | @ForbesUnder30 | #RadOnc | #cancer researcher | „Lass dir Alles geschehn: Schönheit und Schrecken.“
Manhattan, NY
Joined May 2018
📜 I am honored to share our work, "Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysis," published in @TheLancetOncol. 🇹🇭🇵🇭🇮🇩🇻🇳🇰🇭🇲🇲🇲🇾🇹🇱🇧🇳🇱🇦🇸🇬. Thank you Dr @FreddieBray_, @IARCWHO, and our truly #global team. 🔗
7
24
57
📜 In @JCOGO_ASCO, we highlight strengths & challenges in access to #immunotherapy for people w #cancer in #Southeast Asia. 👉 Grateful to Dr Adrian Go & team! @francesvho @erin_feliciano @IyengarPuneeth @fredtingmd @KVanLoonMD. 🇹🇭🇵🇭🇮🇩🇻🇳🇰🇭🇲🇲🇲🇾🇹🇱🇧🇳🇱🇦🇸🇬. 🔗
New in @JCOGO_ASCO: Go, @EChrisDee, and colleagues share an impactful commentary on barriers to immunotherapy access for patients with cancer in Southeast Asia. 👏🏻.
0
1
4
RT @KristineLacuna: Fantastic event dedicated to education and the impact of prostate cancer on our patients, hosted by @WeillCornell @WCMG….
0
5
0
RT @Adam_Weiner535: 🚨Updated data from the FLAME trial🚨. @JCO_ASCO . 🔥Focally boosting intraprostatic MRI lesions improved biochemical DFS….
0
20
0
RT @JournalCancer: New from @NarjustFlorezMD et al 🔥 | This article reports consensus recs & ongoing Qs for management that were generated….
0
14
0
RT @NiuSanford: ctDNA in CRC with @KristenCiombor! . Here we discuss:.-recent MRD trials (DYNAMIC III, etc).-endpoints.-current NCCN recs.-….
0
24
0
📜 Led by Dr @Jonas_Willmann, we validate distant metastasis velocity in international cohorts, underscoring #metastatic #trajectories of #cancer. 🙏 Drs @NAndratschke @Mat_Guc @IyengarPuneeth @SahgalArjun @UmbertoRicardi @DrOlsonOncology & team!. 🔗
Distant failure after SBRT for oligometastatic disease is a common pattern of progression. Yet, we lack validated post-progression models to guide treatment. We tested whether Distant Metastasis Velocity (DMV) can fill this gap - and validated it across multinational cohorts 🧵
0
3
21
RT @EChrisDee: 📜 In @ThyroidJournal led by Justin Choi & Dr @IMRTLee, we present long-term results of #EBRT w/wo concurrent #chemo in #pati….
0
4
0
First MSKCC rad onc open house session is happening today at 8pm EST! ☢️☢️☢️. @MSKCancerCenter @MSK_RadOnc . @KaitlynLapen @NikMankuzhy @alexgoglia @roshalp @jeffmeng0 @DanielGorovets . #MedTwitter #radonc.
Want to learn more about what #radonc training is like at @MSKCancerCenter @MSK_RadOnc? ☢️☢️☢️. Come join us virtually on 20 Aug and 22 Sept 2025 at 8pm ET!. @KaitlynLapen @roshalp @NikMankuzhy @jeffmeng0 @alexgoglia . #medtwitter #radiationoncology #eras.
0
4
14
RT @marklewismd: Oncologists are constantly walking the tightrope between hope & hype but I like to think we are in an era of legitimate op….
0
21
0
RT @MSKCME: Join us for a complimentary virtual event hosted by @MSKCancerCenter, dedicated to amplifying the art and science of hospice an….
0
7
0
RT @m_mutebi: Surgical research saves lives beyond the OR. In Africa, it turns “I think this will help” into “This is saving lives.” . Le….
0
7
0
RT @ChadTangMD: Amazing review led by @NoraSundahl, with some great coauthors too! @_ShankarSiva @DrChoueiri.
0
7
0
RT @NiuSanford: Here is a video on management of 4 common lower GI radiotherapy toxicities:. 1. Radiation dermatitis.2. Diarrhea.3. Acute R….
0
83
0
RT @HimanshuNagarMD: Join us at #ASTRO25 for GU Tumor Board: Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment S….
0
8
0
RT @APCCC_Lugano: Factors associated with #ProstateCancer screening among Hispanic men: Results from the Hispanic Community Health Study/St….
0
8
0
